home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

118.61 -5.79 (-4.65%)

Streaming Delayed Price Updated: 11:48 AM EDT, Mar 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2

...

18 19 20 21 22 23 24 25 26

...

37 38 Next >

The Next Generation Of Cancer Vaccines Are Coming; What That Means For Moderna And Other Biotech Stocks ↗

February 24, 2023

Startling cancer vaccine results from Moderna may point to the next big thing in biotech.

Via Investor's Business Daily

Home Healthcare Equipment Market Trends, Volume, Growth Strategies Forecast Report 2023

February 16, 2023

Some of the major players profiled in the Home Healthcare Equipment Market report are Abbott Laboratories (US), F. Hoffman-La Roche (Switzerland), QIAGEN (Germany), Thermo Fisher Scientific (US),...

Via SBWire

Topics Economy

Cri-Du-Chat Syndrome Market Demand Trends Size Overview Analysis 2022-2029

February 14, 2023

Global Cri-du-chat Syndrome Market to Witness Huge Growth by Key Players: Centogene AG, Eurofins Scientific, Laboratory Corporation of America Holdings, Quest Diagnostics, PerkinElmer Inc., Natera,...

Via SBWire

7 Stocks to Buy and Hold for the Next 20 Years ↗

February 12, 2023

When choosing stocks to buy and hold for the next 20 years, pick companies with strong comparative advantages in durable sectors.

Via InvestorPlace

DNA-Reading Giant Illumina Topples On Wide Profit Miss ↗

February 07, 2023

Sales narrowly topped expectations, however.

Via Investor's Business Daily

If You Invested $100 In This Stock 10 Years Ago, You Would Have $400 Today ↗

February 07, 2023

Via Benzinga

Earnings Preview For Illumina ↗

February 06, 2023

Via Benzinga

7 Analysts Have This to Say About Illumina ↗

January 25, 2023

Via Benzinga

Cramer Likens This Stock To 'A Fine Merlot': It's Down 1% In 2023, So 'I Would Buy All You Can Right Here' ↗

February 08, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Parker-Hannifin Corp (NYSE: PH) is "just the kind of industrial I’ve been recommending."

Via Benzinga

New Survey Data Shows Innovation Teams at Large Companies Are Focusing More on Near-Term Initiatives, but Internal Politics and Culture Remain Top Challenges

February 07, 2023

InnoLead has released a 2023 update to its popular Benchmarking Innovation Impact research with KPMG LLP.

Via Newswire.com

US Stocks Pause Ahead Of Powell's Speech: Analyst Warns Of Retest Of October Lows As Market, Economic Data Conspire Against Monetary Policy ↗

February 07, 2023

Stocks look set for another nervous session on Tuesday as traders look ahead to comments from Fed Chair Jerome Powell and another batch of earnings reports. Cues From Monday’s Trading:

Via Benzinga

Illumina's Woes Mount As Guidance Lags And Grail Controversy Continues ↗

January 10, 2023

Illumina projected far lighter-than-expected profit guidance for 2023.

Via Investor's Business Daily

Is Illumina Cheap or Expensive? ↗

December 14, 2022

It depends on which numbers you focus on.

Via The Motley Fool

What 7 Analyst Ratings Have To Say About Illumina ↗

December 07, 2022

Via Benzinga

Looking Into Illumina's Return On Invested Capital ↗

November 21, 2022

Via Benzinga

Catalent Hits Four-Month High As Danaher Reportedly Mulls A Takeover ↗

February 06, 2023

Danaher is reportedly looking to add to its wheelhouse to compete with Thermo.

Via Investor's Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For January 25, 2023 ↗

January 25, 2023

Via Benzinga

Healthcare Sector Is Lagging As We Enter 2022 Earnings Season ↗

January 23, 2023

The healthcare sector is perceived as defensive but in 2023 there is more investor appetite for risk based on the QQQ comeback and the XBI strength.

Via Talk Markets

Stock Market Rally Gains Steam As Inflation Cools; Tesla Price Cuts, Big Earnings In Focus: Weekly Review ↗

January 13, 2023

Sharp Tesla price cuts and some notable earnings were in focus.

Via Investor's Business Daily

Illumina Shares Tank After Annual Guidance Fall Short Of Expectations ↗

January 10, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 10, 2023

Via Benzinga

US Stocks Show Tentativeness On Tuesday As Traders Wait On Word From Fed Chair Jerome Powell ↗

January 10, 2023

U.S. stocks look set to start Tuesday’s session on a nervous note as traders may prefer to wait and watch the inflation data before making their next moves.

Via Benzinga

Universal Sequencing Technology Corporation (UST) partners with TATAA Biocenter to offer Long Read Sequencing Services with TELL-Seq Linked-Read Tech

January 10, 2023

CARLSBAD, Calif. - Jan. 10, 2023 - PRLog -- Universal Sequencing Technology Corporation (UST) announces today, January 10th, 2022, that it has partnered with TATAA Biocenter, one of our key...

Via PRLog

Topics Intellectual Property

QIAGEN Acquires Verogen Strengthening Its Position In Human ID / Forensics ↗

January 09, 2023

Via Benzinga

What Does Illumina's Debt Look Like? ↗

January 04, 2023

Shares of Illumina Inc. (NASDAQ:ILMN) moved higher by 1.43% in the past three months. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its...

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

December 12, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Genotek (Yerevan, Armenia), Professor Tamara Sarkisian and Illumina open a world-class genomic laboratory

November 18, 2022

The modern laboratory complex, complete with genomic sequencers and microarray analysis platforms from the U.S. company Illumina, helps solve problems in medical research and agriculture. In addition...

Via PRUnderground

Topics Economy

GRAIL CCGA Discovery Results Published in Cancer Cell Reveal Methylation as Promising DNA Hallmark for Multi-Cancer Early Detection

November 17, 2022

From GRAIL, LLC

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023 ↗

January 05, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022 ↗

December 12, 2022

Via Benzinga

< Previous 1 2

...

18 19 20 21 22 23 24 25 26

...

37 38 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com